Total Payments
$729.76
2024 Payments
$189.10
Companies
12
Transactions
16
Medicare Patients
3,206
Medicare Billing
$534,816
Payment Breakdown by Category
Food & Beverage$633.37 (86.8%)
Education$96.39 (13.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $633.37 | 14 | 86.8% |
| Education | $96.39 | 2 | 13.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $172.12 | 4 | $0 (2023) |
| Amgen Inc. | $142.80 | 1 | $0 (2024) |
| Travere Therapeutics, Inc. | $126.91 | 1 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $69.99 | 1 | $0 (2018) |
| Genentech USA, Inc. | $41.90 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $39.39 | 1 | $0 (2017) |
| Veloxis Pharmaceuticals, Inc. | $33.69 | 1 | $0 (2019) |
| GlaxoSmithKline, LLC. | $26.40 | 1 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $23.65 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $22.65 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $189.10 | 3 | Amgen Inc. ($142.80) |
| 2023 | $325.43 | 6 | Takeda Pharmaceuticals U.S.A., Inc. ($172.12) |
| 2020 | $19.42 | 1 | Alexion Pharmaceuticals, Inc. ($19.42) |
| 2019 | $33.69 | 1 | Veloxis Pharmaceuticals, Inc. ($33.69) |
| 2018 | $122.73 | 4 | SANOFI-AVENTIS U.S. LLC ($69.99) |
| 2017 | $39.39 | 1 | Novartis Pharmaceuticals Corporation ($39.39) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | NULOJIX (Biological) | Food and Beverage | Cash or cash equivalent | $22.65 | General |
| Category: Immunology | ||||||
| 07/25/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: CRITICAL CARE | ||||||
| 04/25/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $142.80 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/22/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Education | In-kind items and services | $26.40 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2023 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2023 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $2.92 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $126.91 | General |
| 08/16/2023 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: IMMUNOLOGY | ||||||
| 06/05/2023 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $119.04 | General |
| Category: IMMUNOLOGY | ||||||
| 02/19/2020 | Alexion Pharmaceuticals, Inc. | Ultomiris (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Immunology | ||||||
| 07/18/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Food and Beverage | In-kind items and services | $33.69 | General |
| Category: Immunosuppressant | ||||||
| 11/08/2018 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: ONCOLOGY | ||||||
| 09/12/2018 | SANOFI-AVENTIS U.S. LLC | JEVTANA (Drug) | Education | In-kind items and services | $69.99 | General |
| Category: ONCOLOGY | ||||||
| 08/06/2018 | Genentech USA, Inc. | Rituxan (Biological) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: BioOncology/Immunology | ||||||
| 05/07/2018 | Genentech USA, Inc. | Rituxan (Biological) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: BioOncology/Immunology | ||||||
| 11/08/2017 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Food and Beverage | In-kind items and services | $39.39 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 851 | 1,616 | $587,414 | $149,249 |
| 2022 | 10 | 855 | 1,530 | $574,666 | $143,899 |
| 2021 | 10 | 700 | 1,182 | $423,881 | $118,312 |
| 2020 | 10 | 800 | 1,478 | $481,695 | $123,356 |
Total Patients
3,206
Total Services
5,806
Medicare Billing
$534,816
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 205 | 432 | $200,916 | $51,124 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 346 | 654 | $210,140 | $51,037 | 24.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 67 | 184 | $65,944 | $18,615 | 28.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 89 | 194 | $46,901 | $12,744 | 27.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 44 | 49 | $20,775 | $5,328 | 25.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 27 | 28 | $17,478 | $4,164 | 23.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 42 | 44 | $15,729 | $4,114 | 26.2% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 31 | 31 | $9,531 | $2,124 | 22.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 205 | 414 | $196,020 | $49,495 | 25.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 354 | 557 | $178,481 | $44,626 | 25.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 99 | 324 | $106,864 | $28,047 | 26.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 30 | 32 | $20,430 | $5,218 | 25.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 36 | 40 | $17,383 | $4,519 | 26.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 44 | 74 | $16,996 | $4,483 | 26.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 36 | 37 | $12,650 | $3,337 | 26.4% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 29 | 30 | $9,642 | $2,377 | 24.7% |
| 50200 | Needle biopsy of kidney | Facility | 2022 | 11 | 11 | $13,809 | $1,167 | 8.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 11 | 11 | $2,391 | $629.99 | 26.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 189 | 418 | $178,348 | $52,725 | 29.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 266 | 355 | $105,695 | $28,941 | 27.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 77 | 217 | $72,853 | $19,240 | 26.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 25 | 28 | $18,248 | $4,471 | 24.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 26 | 27 | $11,964 | $3,053 | 25.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 30 | 47 | $10,982 | $2,920 | 26.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 27 | 27 | $9,392 | $2,504 | 26.7% |
About Dr. Reiad Najjar, MD
Dr. Reiad Najjar, MD is a Nephrology healthcare provider based in West Hollywood, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2008. The National Provider Identifier (NPI) number assigned to this provider is 1043498397.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Reiad Najjar, MD has received a total of $729.76 in payments from pharmaceutical and medical device companies, with $189.10 received in 2024. These payments were reported across 16 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($633.37).
As a Medicare-enrolled provider, Najjar has provided services to 3,206 Medicare beneficiaries, totaling 5,806 services with total Medicare billing of $534,816. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location West Hollywood, CA
- Active Since 02/07/2008
- Last Updated 03/29/2024
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1043498397
Products in Payments
- LIVTENCITY (Drug) $172.12
- KRYSTEXXA (Biological) $142.80
- JEVTANA (Drug) $69.99
- Rituxan (Biological) $41.90
- ZORTRESS (Drug) $39.39
- Envarsus (Drug) $33.69
- BENLYSTA (Biological) $26.40
- TERLIVAZ (Drug) $23.65
- NULOJIX (Biological) $22.65
- Ultomiris (Drug) $19.42
- THYMOGLOBULIN (Drug) $10.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in West Hollywood
Mark Barats, M.d, M.D
Nephrology — Payments: $46,849
Nephrology $46,849
Jun Shoji, M.d, M.D
Nephrology — Payments: $5,359
Nephrology $5,359
Dr. Ramin Gabbai, Md, MD
Nephrology — Payments: $1,965
Nephrology $1,965
Mr. Ronald Lang, M.d, M.D
Nephrology — Payments: $1,745
Nephrology $1,745
Dr. Rana Sandhu
Nephrology — Payments: $54.52
Nephrology $54.52
Dr. Sindhu Chandran, M.b.,B.s, M.B.,B.S
Nephrology — Payments: $22.65
Nephrology $22.65